PUMA and P.A.M. arrive with the fourth volume of BIO/VERSE - HIGHXTAR.
Puma Biotechnology Announces Exclusive License Agreement with Takeda for the Development and Commercialization of Alisertib, an Investigational Aurora Kinase A Inhibitor | Business Wire
Puma Biotechnology Announces Exclusive License Agreement with Takeda for the Development and Commercialization of Alisertib, an Investigational Aurora Kinase A Inhibitor | Business Wire
The P.A.M. and PUMA Colab Is Available Now - Sneaker Freaker